Finally, miR-7 mimics can reduce the mTOR levels through the PI3K/AKT/mTOR signaling pathway and thereby reduce hyperglycemia-induced damage in RPECs, which indicates that it is a potential therapeutic strategy for the prevention and treatment of DR [142]. This evidence concerns the gene MTOR and Hyperglycemia.